- Home
- ALLR vs NUWE Comparison
ALLR vs NUWE Comparison
Compare ALLR & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- NUWE
- Stock Information
- Founded
- ALLR 2004
- NUWE 1999
- Country
- ALLR United States
- NUWE United States
- Employees
- ALLR N/A
- NUWE N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ALLR Health Care
- NUWE Health Care
- Exchange
- ALLR Nasdaq
- NUWE Nasdaq
- Market Cap
- ALLR 4.0M
- NUWE 3.9M
- IPO Year
- ALLR N/A
- NUWE N/A
- Fundamental
- Price
- ALLR $1.07
- NUWE $0.93
- Analyst Decision
- ALLR
- NUWE Strong Buy
- Analyst Count
- ALLR 0
- NUWE 1
- Target Price
- ALLR N/A
- NUWE $17.00
- AVG Volume (30 Days)
- ALLR 1.4M
- NUWE 61.5K
- Earning Date
- ALLR 05-13-2025
- NUWE 05-06-2025
- Dividend Yield
- ALLR N/A
- NUWE N/A
- EPS Growth
- ALLR N/A
- NUWE N/A
- EPS
- ALLR N/A
- NUWE N/A
- Revenue
- ALLR N/A
- NUWE $8,740,000.00
- Revenue This Year
- ALLR N/A
- NUWE $22.96
- Revenue Next Year
- ALLR N/A
- NUWE $29.97
- P/E Ratio
- ALLR N/A
- NUWE N/A
- Revenue Growth
- ALLR N/A
- NUWE N/A
- 52 Week Low
- ALLR $0.61
- NUWE $0.75
- 52 Week High
- ALLR $103.80
- NUWE $14.00
- Technical
- Relative Strength Index (RSI)
- ALLR 60.94
- NUWE 47.12
- Support Level
- ALLR $0.66
- NUWE $0.86
- Resistance Level
- ALLR $1.06
- NUWE $0.95
- Average True Range (ATR)
- ALLR 0.11
- NUWE 0.08
- MACD
- ALLR 0.04
- NUWE 0.01
- Stochastic Oscillator
- ALLR 88.37
- NUWE 76.71
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.